AHK-Cu

Overview

AHK-Cu occupies a specific niche in the copper peptide space: hair growth promotion. While GHK-Cu has become the dominant copper peptide in skin care, AHK-Cu has attracted research attention specifically for follicular applications, with preliminary data suggesting distinct follicle-specific activity.

Comparison to GHK-Cu

Both AHK-Cu and GHK-Cu are copper tripeptides with skin-remodeling properties, but their amino acid sequences differ (Ala-His-Lys vs Gly-His-Lys), leading to somewhat different receptor and receptor interactions. AHK-Cu’s follicle-specific effects may reflect preferential activation of keratinocyte and follicle stem cell pathways.

Evidence Gap

The evidence for AHK-Cu specifically is substantially thinner than for GHK-Cu. Most of the available data is in vitro or from small studies, without the human double-blind trials that support GHK-Cu’s skin claims. Independent clinical validation is the primary need.

Practical Application

AHK-Cu is incorporated into scalp serums and topical hair loss formulations, typically at concentrations of 0.1-2%. It is often combined with other hair growth actives (redensyl, capixyl, procapil) in formulations designed for androgenic alopecia and diffuse hair thinning.